EmGenisys Secures $1.5M Seed Round to Advance AI-Powered Embryo Evaluation
EmGenisys, an animal health technology company specializing in real-time AI analysis of embryo viability, announced the close of a $1.5 million seed financing round, which was oversubscribed and led by Grit Road Partners.